DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Market Level Insights

Formerly known as Decision Resources, our Market Level Insights provide competitive and business intelligence on the leading players in the biopharmaceutical space, as well as analysis on key trends and industry events to accurately assess market potential. We combine qualitative and quantitative expertise in syndicated research and interactive online platforms to guide commercialization decision making.

Already a Subscriber?

Access your interactive business intelligence platforms.

LAMP Pharmaview

Biosimilars Insights

Evaluation of the risks, opportunities, and strategies underlying biosimilars development and defense.

 

Pharmaview

Obtain a full view of market and competitive positioning with reliable and up-to-date product analysis and worldwide net sales roll ups by molecule, therapy area, and company.

 

 

Label Analysis and Monitoring

Utilize a multi-client subscription service to enable drug label and label claim comparisons across geographies and therapeutic areas.

 

Our latest thoughts and commentary

 

Latest articles

JAK inhibitors in IBD

On the Way to Becoming JAKs of All Trades On July 13th, 2017 Pfizer announced that its application for approval in ulcerative...

More Articles

In the news
News articles citing DRG analysts data.
More News